UC San Diego Health Offers Novel Gene Therapy for Bladder Cancer
UC San Diego Health is the first health system in San Diego County to offer novel gene therapy for bladder cancer.
UC San Diego Health is the first health system in San Diego County to offer novel gene therapy for bladder cancer.
Researchers at University of California San Diego show that a molecule which shuttles damaging inflammatory cells into cancer tumors also shuttles inflammatory cells into lung tissue infected with COVID-19 — and that the molecule can be suppressed with a repurposed cancer drug. The work represents a new approach to preventing irreversible organ damage in infectious diseases.
UC San Diego researchers have discovered another factor that affects the composition of the gut microbiome: time of day.
UC San Diego Health offers the only program in San Diego for hereditary hemorrhagic telangiectasia (HHT), a condition that causes excessive bleeding.
Loosening local, state and federal regulations on cannabis and psychedelics has increased Americans' interest in microdosing, according to a study from researchers at the University of California San Diego. Published in JAMA Health Forum, the study found that the rate of microdosing-related Google searches grew by 1250% from 2015 to 2023, with over three million searches in 2023 alone.
Chief Administrative Officer for Health Justice, Equity, Diversity and Inclusion discusses how her childhood influences mission to confront health disparities.
CNBC, March 24
The San Diego Union-Tribune, March 16
The San Diego Union-Tribune, March 10
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.